The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Diurnal trio dip in after EMA submission in December

Mon, 16th Jan 2017 15:08

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year.Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a price of 108p.Diurnal, which floated on AIM in December 2015 market authorisation in late 2017, last month submitted the marketing application to the European Medicines Agency for Infacort, which has the potential to be the first licensed treatment in Europe for Adrenal Insufficiency (AI) specifically designed for use in children under six years of age.This was made on the back of "highly statistically significant" data from clinical trials, with the EMA having already approved a paediatric investigation plan (PIP) for Infacort that set out the regulatory pathway to market authorisation.Diurnal anticipates market authorisation in late 2017, with product revenues expected from early 2018 and the company estimating the total market for paediatric AI and the related condition Congenital Adrenal Hyperplasia in Europe is approximately $28m per year.Top Director BuysDiurnal Group (DNL)Director name: Allen,PeterAmount purchased: 40,000 @ 105.00pValue: £42,000.00Diurnal Group (DNL)Director name: Goddard,JohnAmount purchased: 9,248 @ 108.00pValue: £9,987.84Diurnal Group (DNL)Director name: Williams,SamAmount purchased: 9,248 @ 108.00pValue: £9,987.84Jardine Lloyd Thompson Group (JLT)Director name: Walsh,NicholasAmount purchased: 1,000 @ 997.42pValue: £9,974.25Haydale Graphene Industries (HAYD)Director name: Gibbs,Raymond (Ray) JohnAmount purchased: 4,353 @ 160.00pValue: £6,964.80Fidelity Asian Values (FAS)Director name: Stott,GrahameAmount purchased: 4,000 @ 31.00pValue: £1,240.00Vodafone Group (VOD)Director name: Schellekens,Ronald Amount purchased: 118 @ 212.45pValue: £250.69Sthree (STHR)Director name: Smith,AlexAmount purchased: 65 @ 319.00pValue: £207.35Sthree (STHR)Director name: Elden,GaryAmount purchased: 64 @ 319.00pValue: £204.16Supergroup (SGP)Director name: Sutherland ,EuanAmount purchased: 9 @ 1,712.00pValue: £154.08Supergroup (SGP)Director name: Cartwright,Andrea Amount purchased: 9 @ 1,712.00pValue: £154.08Aviva (AV.)Director name: Amin,NitinbhaiAmount purchased: 31 @ 480.80pValue: £149.05Shoe Zone (SHOE)Director name: Davis ,Nicholas (Nick)Amount purchased: 7,000 @ 1.80pValue: £126.00Top Director SellsRenew Holdings (RNWH)Director name: Samuel,JohnAmount sold: 112,518 @ 434.00pValue: £488,328.14Lindsell Train Inv Trust (LTI)Director name: Landman,RoryAmount sold: 100 @ 86,500.00pValue: £86,500.00
More News
11 May 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Read more
15 Apr 2020 14:32

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

Read more
1 Apr 2020 14:47

Diurnal Gets European Marketing Authorisation For Chronocort

Diurnal Gets European Marketing Authorisation For Chronocort

Read more
6 Mar 2020 17:12

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

Read more
6 Mar 2020 12:40

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Read more
6 Mar 2020 10:07

Diurnal raises at least ?7m through conditional placing

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at least ?7m before expenses, at a price of 32p per new share.

Read more
5 Mar 2020 17:21

Diurnal Group Names Director Sam Williams Interim Chair

Diurnal Group Names Director Sam Williams Interim Chair

Read more
13 Feb 2020 13:07

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Read more
13 Feb 2020 09:47

Diurnal clears FDA hurdle for 'Alkindi Sprinkle'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydrocortisone granules in capsules for opening and to be known in the US as 'Alkindi Sprinkle', has been accepted for review by the US Food and Drug Administration (FDA).

Read more
11 Feb 2020 13:45

Diurnal narrows loss as it progresses drugs to market

(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it said reflected improved revenues and a reduction in clinical development expenses for the period.

Read more
11 Feb 2020 09:20

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Read more
4 Feb 2020 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jan 2020 11:17

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Read more
16 Dec 2019 13:20

Diurnal Submits Market Authorisation Application For Chronocort

Diurnal Submits Market Authorisation Application For Chronocort

Read more
2 Dec 2019 14:40

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.